Kane Biotech

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Kane Biotech’s mission is to develop innovative technologies that provide significant and novel health care solutions aimed at improving patient outcomes.

Kane Biotech’s vision is to be the premier biotechnology company in the world, providing innovative solutions that improve the quality of patient care.

Kane Biotech has received numerous awards, including the Technology Commercialization Award by the Canadian Innovation Exchange and High Growth Company of the Year award by the Canadian Taxpayers Federation.